Clinical Stage, SMALL MOLECULE Treatments for Rare & Pandemic Diseases

Proven Safety | Clinical Stage | Accelerated Development

Clinical Stage, SMALL MOLECULE Treatments for Rare & Pandemic Diseases

Proven Safety | Clinical Stage | Accelerated Development

About Us

Our Technology

Experienced Management

Development Pipeline

CMTx Biotech is commercializing proprietary small-molecules for the treatment of rare, orphan diseases to improve critical patient outcomes

Development Pipeline

Experienced Management

Development Pipeline

Our lead drug candidate has completed IND-enabling studies and has been tested safely in humans in variety other indications, dramatically accelerating our path to human clinical trials and market approval.

Experienced Management

Our management and advisory team is composed of a seasoned group of scientists, business managers, technology commercialization and licensing experts that have multiple successes in both drug development and commercialization as well as licensing and technology transfer.

Management Team & founders

Joseph Scaduto, MS, MBA

Lorne Golub, DMD, MSc, MD (Honorary)

Co-Founder & Chief Executive Officer

Lorne Golub, DMD, MSc, MD (Honorary)

Scientific Co-Founder

James Keane, BS, MBA

Lorne Golub, DMD, MSc, MD (Honorary)

Christopher Czura, PhD

Co-Founder & Chief Operating Officer

Christopher Czura, PhD

VP Scientific Affairs

JoAnn Wilson, PhD

Christopher Czura, PhD

JoAnn Wilson, PhD

VP Chemistry, Manufacturing and Controls

Janet S Lee, PhD

Christopher Czura, PhD

JoAnn Wilson, PhD

VP, Clinical Research

Carlos Velez, PhD, MBA

Ashley Holub, MA ,PhD (c)

VP Business Development

Ashley Holub, MA ,PhD (c)

Director, Clinical Research

Sonny Granger

Ashley Holub, MA ,PhD (c)

Sonny Granger

Co-Founder & Charcot-Marie-Tooth Disease Patient Advocate

Scientific, Clinical, and Strategic Advisors

Sharon Nachman, MD

Associate Dean of Research

Stony Brook University School of Medicine

Hani Aiash, MD/PhD

Sharon Nachman, MD

Clinical Assistant Professor

SUNY Upstate Medical University

Andrew Protter

Sharon Nachman, MD

Andrew Protter

Chief Scientific Officer

Auransa, Inc.

Peter Young

Michelle Rudek (Renaut)

Andrew Protter

Venture Partner

Pappas Capital

Michelle Rudek (Renaut)

Professor of Oncology and Medicine (Clinical Pharmacology) at Johns Hopkins University

Jay Steinberg, DO

Michelle Rudek (Renaut)

Director of Thoracic Surgery

Jefferson Health New Jersey

Rober Levy, MD

CoFounder

PromptCareMD

Daniel Keene

Rober Levy, MD

Director, Patient Services Innovation, Novartis

Articles & Publications

CMTx Biotech successfully submitted a Clinical Trial Planning grant application to the National Center for Advancing Translational Sciences (NCATS) this week requesting financial support to design a Phase II clinical study evaluating the safety and efficacy of the company’s lead drug candidate, incyclinide (CMT-3 / COL-3), in hospitalized COVID-19 patients. The company also proposed to engage the U.S. Food and Drug Administration (FDA) in a pre-IND meeting, as well as to prepare and submit an Investigational New Drug (IND) application. Special thanks to our clinical collaborators, Dr. Sharon nachman (Stony Brook University) and Dr. Hani Aiash (SUNY Upstate Medical University), as well as Chris Czura, PhD, Jo Ann Zbur Wilson, Janet S Lee, PhD, Ashley Holub, Daniel Keene, James Keane, MBA, Joseph Scaduto and Andy Protter for their contributions to the written proposal.

https://lnkd.in/d8AKsHS

Clinical Stage, SMALL MOLECULE Treatments for Rare & Pandemic Diseases

Clinical Stage, SMALL MOLECULE Treatments for Rare & Pandemic Diseases

About Us

Our Technology

Experienced Management

Development Pipeline

Development Pipeline

Experienced Management

Development Pipeline

Experienced Management

Experienced Management

Experienced Management

Management Team & founders

Joseph Scaduto, MS, MBA

Lorne Golub, DMD, MSc, MD (Honorary)

Lorne Golub, DMD, MSc, MD (Honorary)

Lorne Golub, DMD, MSc, MD (Honorary)

Lorne Golub, DMD, MSc, MD (Honorary)

Lorne Golub, DMD, MSc, MD (Honorary)

James Keane, BS, MBA

Lorne Golub, DMD, MSc, MD (Honorary)

Christopher Czura, PhD

Christopher Czura, PhD

Christopher Czura, PhD

Christopher Czura, PhD

JoAnn Wilson, PhD

Christopher Czura, PhD

JoAnn Wilson, PhD

Janet S Lee, PhD

Christopher Czura, PhD

JoAnn Wilson, PhD

Carlos Velez, PhD, MBA

Ashley Holub, MA ,PhD (c)

Ashley Holub, MA ,PhD (c)

Ashley Holub, MA ,PhD (c)

Ashley Holub, MA ,PhD (c)

Ashley Holub, MA ,PhD (c)

Sonny Granger

Ashley Holub, MA ,PhD (c)

Sonny Granger

Scientific, Clinical, and Strategic Advisors

Sharon Nachman, MD

Sharon Nachman, MD

Sharon Nachman, MD

Hani Aiash, MD/PhD

Sharon Nachman, MD

Sharon Nachman, MD

Andrew Protter

Sharon Nachman, MD

Andrew Protter

Peter Young

Michelle Rudek (Renaut)

Andrew Protter

Michelle Rudek (Renaut)

Michelle Rudek (Renaut)

Michelle Rudek (Renaut)

Jay Steinberg, DO

Michelle Rudek (Renaut)

Michelle Rudek (Renaut)

Rober Levy, MD

Rober Levy, MD

Rober Levy, MD

Daniel Keene

Rober Levy, MD

Rober Levy, MD

Subscribe

Find Us Online

Contact Us

Send Message

CMTx Biotech, Inc.

Articles & Publications